vs

Side-by-side financial comparison of HARROW, INC. (HROW) and Piedmont Realty Trust, Inc. (PDM). Click either name above to swap in a different company.

Piedmont Realty Trust, Inc. is the larger business by last-quarter revenue ($143.3M vs $89.1M, roughly 1.6× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs -31.4%, a 38.8% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 0.4%). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 0.0%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

Piedmont Realty Trust, Inc. is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality office properties primarily located in high-growth metropolitan areas across the United States. It serves corporate tenants across multiple industry sectors including technology, professional services, and healthcare, and pursues stable long-term returns for stakeholders via strategic property management and portfolio optimization.

HROW vs PDM — Head-to-Head

Bigger by revenue
PDM
PDM
1.6× larger
PDM
$143.3M
$89.1M
HROW
Growing faster (revenue YoY)
HROW
HROW
+32.9% gap
HROW
33.3%
0.4%
PDM
Higher net margin
HROW
HROW
38.8% more per $
HROW
7.4%
-31.4%
PDM
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
0.0%
PDM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HROW
HROW
PDM
PDM
Revenue
$89.1M
$143.3M
Net Profit
$6.6M
$-45.0M
Gross Margin
79.3%
Operating Margin
17.5%
Net Margin
7.4%
-31.4%
Revenue YoY
33.3%
0.4%
Net Profit YoY
-2.2%
-27.9%
EPS (diluted)
$0.20
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
PDM
PDM
Q1 26
$143.3M
Q4 25
$89.1M
$142.9M
Q3 25
$71.6M
$139.2M
Q2 25
$63.7M
$140.3M
Q1 25
$47.8M
$142.7M
Q4 24
$66.8M
$143.2M
Q3 24
$49.3M
$139.3M
Q2 24
$48.9M
$143.3M
Net Profit
HROW
HROW
PDM
PDM
Q1 26
$-45.0M
Q4 25
$6.6M
$-43.2M
Q3 25
$1.0M
$-13.5M
Q2 25
$5.0M
$-16.8M
Q1 25
$-17.8M
$-10.1M
Q4 24
$6.8M
$-30.0M
Q3 24
$-4.2M
$-11.5M
Q2 24
$-6.5M
$-9.8M
Gross Margin
HROW
HROW
PDM
PDM
Q1 26
Q4 25
79.3%
Q3 25
75.3%
Q2 25
74.5%
Q1 25
67.5%
Q4 24
78.8%
Q3 24
75.6%
Q2 24
74.4%
Operating Margin
HROW
HROW
PDM
PDM
Q1 26
Q4 25
17.5%
Q3 25
20.6%
Q2 25
17.9%
Q1 25
-23.5%
Q4 24
19.3%
Q3 24
2.7%
Q2 24
3.1%
Net Margin
HROW
HROW
PDM
PDM
Q1 26
-31.4%
Q4 25
7.4%
-30.3%
Q3 25
1.4%
-9.7%
Q2 25
7.8%
-12.0%
Q1 25
-37.2%
-7.1%
Q4 24
10.1%
-20.9%
Q3 24
-8.6%
-8.3%
Q2 24
-13.2%
-6.8%
EPS (diluted)
HROW
HROW
PDM
PDM
Q1 26
$-0.10
Q4 25
$0.20
$-0.34
Q3 25
$0.03
$-0.11
Q2 25
$0.13
$-0.14
Q1 25
$-0.50
$-0.08
Q4 24
$0.19
$-0.25
Q3 24
$-0.12
$-0.09
Q2 24
$-0.18
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
PDM
PDM
Cash + ST InvestmentsLiquidity on hand
$72.9M
$2.3M
Total DebtLower is stronger
$250.0M
Stockholders' EquityBook value
$52.4M
$1.5B
Total Assets
$399.5M
$4.0B
Debt / EquityLower = less leverage
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
PDM
PDM
Q1 26
$2.3M
Q4 25
$72.9M
$731.0K
Q3 25
$74.3M
$3.0M
Q2 25
$53.0M
$3.3M
Q1 25
$66.7M
$2.9M
Q4 24
$47.2M
$109.6M
Q3 24
$72.6M
$133.6M
Q2 24
$71.0M
$138.5M
Total Debt
HROW
HROW
PDM
PDM
Q1 26
Q4 25
$250.0M
$2.2B
Q3 25
$347.2M
$2.2B
Q2 25
$250.6M
$2.2B
Q1 25
$256.9M
$2.2B
Q4 24
$262.7M
$2.2B
Q3 24
$230.7M
$2.2B
Q2 24
$236.3M
$2.2B
Stockholders' Equity
HROW
HROW
PDM
PDM
Q1 26
$1.5B
Q4 25
$52.4M
$1.5B
Q3 25
$47.0M
$1.5B
Q2 25
$49.7M
$1.5B
Q1 25
$56.5M
$1.6B
Q4 24
$69.7M
$1.6B
Q3 24
$58.0M
$1.6B
Q2 24
$58.5M
$1.7B
Total Assets
HROW
HROW
PDM
PDM
Q1 26
$4.0B
Q4 25
$399.5M
$4.0B
Q3 25
$363.1M
$4.0B
Q2 25
$345.0M
$4.0B
Q1 25
$364.2M
$4.0B
Q4 24
$389.0M
$4.1B
Q3 24
$351.5M
$4.1B
Q2 24
$306.6M
$4.2B
Debt / Equity
HROW
HROW
PDM
PDM
Q1 26
Q4 25
4.77×
1.49×
Q3 25
7.39×
1.43×
Q2 25
5.05×
1.41×
Q1 25
4.55×
1.40×
Q4 24
3.77×
1.40×
Q3 24
3.98×
1.36×
Q2 24
4.04×
1.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
PDM
PDM
Operating Cash FlowLast quarter
$8.4M
Free Cash FlowOCF − Capex
$8.1M
FCF MarginFCF / Revenue
9.1%
Capex IntensityCapex / Revenue
0.4%
110.3%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
PDM
PDM
Q1 26
Q4 25
$8.4M
$140.6M
Q3 25
$16.6M
$35.8M
Q2 25
$-803.0K
$50.1M
Q1 25
$19.7M
$3.7M
Q4 24
$-17.8M
$198.1M
Q3 24
$3.0M
$42.9M
Q2 24
$-2.7M
$66.8M
Free Cash Flow
HROW
HROW
PDM
PDM
Q1 26
Q4 25
$8.1M
Q3 25
$16.4M
Q2 25
$-969.0K
Q1 25
$19.5M
Q4 24
$-18.3M
Q3 24
$2.3M
Q2 24
$-3.1M
FCF Margin
HROW
HROW
PDM
PDM
Q1 26
Q4 25
9.1%
Q3 25
22.9%
Q2 25
-1.5%
Q1 25
40.8%
Q4 24
-27.4%
Q3 24
4.8%
Q2 24
-6.3%
Capex Intensity
HROW
HROW
PDM
PDM
Q1 26
110.3%
Q4 25
0.4%
Q3 25
0.3%
Q2 25
0.3%
Q1 25
0.4%
Q4 24
0.8%
Q3 24
1.2%
Q2 24
0.7%
Cash Conversion
HROW
HROW
PDM
PDM
Q1 26
Q4 25
1.27×
Q3 25
16.26×
Q2 25
-0.16×
Q1 25
Q4 24
-2.62×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons